Publications by authors named "Lucas Sejournet"

Purpose: To compare refractive outcomes of the foldable intraocular lens sutureless scleral fixated sutureless (Carlevale® FIL-SSF) with the iris-claw lens (Artisan®).

Methods: This retrospective study included consecutive patients who underwent a FIL-SSF implantation or an iris-claw implantation between January 2020 and November 2022 in the ophthalmology departments of Hospices Civils de Lyon (France).

Results: A total of 271 eyes from 265 patients were included: 96 eyes in the FIL-SSF group and 175 eyes in the iris-claw group.

View Article and Find Full Text PDF
Article Synopsis
  • Diabetic macular edema (DME) is a common issue linked to diabetic retinopathy that often requires long-term treatment options like the fluocinolone acetonide (FAc) implant.
  • Although the FAc implant can be effective and is generally well tolerated, it may cause side effects such as ocular hypertension and cataracts, necessitating caution when prescribing.
  • The review aims to give clinicians a comprehensive understanding of the FAc implant, helping them make informed decisions and effectively implement its use in DME management.
View Article and Find Full Text PDF

Background: To describe and analyze the real-life refractive, functional and safety outcomes of the Clareon® intraocular lens (IOL) after 3 years.

Methods: Data was collected retrospectively for observational purposes between July 2017 and December 2019 in the ophthalmology department of Desgenettes military hospital in Lyon, France. Eyes that underwent cataract surgery with Claeron® implantation were consecutively included.

View Article and Find Full Text PDF

Purpose: To compare the impact of total corneal astigmatism (TCA) estimated with the Abulafia-Koch formula (TCA) versus measured by Total Keratometry (TK), swept-source optical coherence tomography (OCT) coupled with telecentric keratometry (TCA) on the refractive outcomes after cataract surgery with toric intraocular lens (IOL) implantation.

Methods: Two hundred one eyes of 146 patients who underwent cataract surgery with toric IOL implantation (XY1AT; HOYA Corporation) were included in this single-center, retrospective study. For each eye, TCA (estimated from the anterior keratometry values measured with the IOLMaster 700 [Carl Zeiss Meditec AG]) and TCA (measured using TK IOLMaster 700) were entered into the HOYA Toric Calculator.

View Article and Find Full Text PDF

Aim: To assess the efficacy of focal photocoagulation of capillary macroaneurysms (CMA) to reduce the burden of intravitreal injections (IVI) in patients with macular edema (ME).

Materials And Methods: Retrospective multicenter study in patients with diabetic ME or ME secondary to retinal vein occlusion (ME-RVO). CMA associated with ME were selectively photocoagulated.

View Article and Find Full Text PDF

Purpose: Steroid-induced ocular hypertension (OHT) occurs in about a third of cases after dexamethasone implant (DEXi) intravitreal injection (IVI), for which treatment discontinuation may be required. The aim of this study was to assess the benefit of selective laser trabeculoplasty (SLT) in patients who developed transient OHT after DEXi injection to prevent subsequent steroid-induced OHT peaks during reinjections.

Methods: A real-life, retrospective, and observational study was conducted to assess the intraocular pressure (IOP) after SLT in steroid responders after DEXi injection (IOP > 21 mmHg).

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the importance of therapeutic drug monitoring (TDM) for adalimumab (ADA) in managing intraocular inflammation in chronic non-infectious uveitis (CNIU) patients.
  • Researchers conducted a retrospective analysis involving 44 patients treated with ADA between June 2003 and July 2019, assessing serum ADA levels and the presence of antibodies against ADA (AAA).
  • Results indicated that TDM helped optimize treatment in non-responders and responders alike, with adjustments leading to improved outcomes in 87% of non-responders, while also allowing responders to reduce their injection frequency without relapses.
View Article and Find Full Text PDF